What are the Magnetic Resonance Imaging (MRI) brain changes associated with Parkinson's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025 • View editorial policy

From the Guidelines

Conventional MRI brain scans in Parkinson's disease often appear normal, and MRI is primarily used to rule out other conditions rather than diagnose Parkinson's itself. However, advanced MRI techniques can reveal subtle changes in the brains of Parkinson's patients, as noted in the study by 1. These include reduced volume and signal changes in the substantia nigra, particularly in its pars compacta region where dopaminergic neurons degenerate.

Key Findings

  • Susceptibility-weighted imaging (SWI) may show loss of the normal "swallow tail" appearance of the substantia nigra.
  • Diffusion tensor imaging can detect microstructural changes in white matter tracts, while functional MRI may reveal altered connectivity patterns in motor networks.
  • Volumetric studies might demonstrate atrophy in specific brain regions including the basal ganglia, brainstem, and certain cortical areas as the disease progresses. These changes correlate with the pathophysiology of Parkinson's, where progressive loss of dopaminergic neurons leads to motor symptoms, as discussed in 1 and further elaborated upon in 2. More advanced disease may show cortical thinning and ventricular enlargement. While these findings are increasingly recognized, they are not yet specific enough for routine clinical diagnosis, which still relies primarily on clinical assessment.

Diagnostic Approach

  • A combination of imaging techniques is often needed for complete evaluation of the patient and to help establish the most likely diagnosis, as suggested by 2.
  • Initial assessment using structural imaging, with MRI preferred over CT, is helpful not only to look for patterns of atrophy, parenchymal abnormality, or abnormal substance deposition but also to exclude other potential etiologies.
  • Advanced MRI techniques, including diffusion tensor imaging, magnetization transfer ratio imaging, and postprocessing techniques such as quantitative volumetric analysis, may be useful in the evaluation of the microstructural makeup of the brain parenchyma, including the integrity of gray matter, white matter, and their connecting neural pathways, as noted in 2.

From the Research

MRI Brain Changes in Parkinson's Disease

  • The study 3 discusses the use of conventional brain MRI and advanced MRI techniques in Parkinson's disease, highlighting their clinical relevance.
  • Conventional brain MRI sequences generally demonstrate limited abnormalities specific for Parkinson's disease, and brain MRI is mainly used to exclude other pathology.
  • Advanced MRI techniques such as susceptibility weighted imaging (SWI), diffusion (tensor) MRI, magnetization transfer imaging (MTI), and functional MRI (f-MRI) have been applied to patient cohorts with Parkinson's disease to improve understanding of pathophysiologic changes.

Diagnostic Markers for Parkinson's Disease

  • The study 3 suggests that advanced MRI techniques hold promise to provide additional diagnostic markers for early stage Parkinson's disease, such as diffusional changes in the orbital-frontal region in the pre-motor phase of Parkinson's disease.
  • However, standardization of scanning protocols and post-processing methods, and validation of diagnostic criteria is crucial for these advanced MRI techniques.
  • Well-designed prospective clinical cohort studies are needed to validate the use of these advanced MRI techniques as diagnostic markers for Parkinson's disease.

Treatment of Parkinson's Disease

  • The studies 4, 5, 6, and 7 discuss the treatment of Parkinson's disease using dopamine agonists, monoamine oxidase B inhibitors, and levodopa.
  • These studies provide information on the effectiveness of different treatments, but do not specifically address MRI brain changes in Parkinson's disease.

Related Questions

What are the abnormal physical exam findings of Parkinson's disease (PD) with toe tapping, specifically describing the characteristic changes in motor function?
How to avoid dopaminergic receptor downregulation?
For a patient presenting with resting tremor, is an MRI (Magnetic Resonance Imaging) of the brain with and without contrast indicated?
What are the effects of hyoscine (scopolamine) butylbromide on Parkinson's disease?
Are there alternatives to Crextont (Rasagiline) medication for Parkinson's disease?
Can the order for bilateral upper extremity (BUE) wrist restraints be renewed and mittens added for a patient with a chest tube to prevent accidental removal?
What is the treatment for Common Variable Immunodeficiency (CVID) with recurrent infections, and when is Tigecycline (tigecycline) indicated?
What is the comparison between Methylprednisolone (Solumedrol) and Dexamethasone (Decadron) in the treatment of acute Chronic Obstructive Pulmonary Disease (COPD)?
What is the best course of action for a patient with hyperglycemia, who was administered 14 units of lispro (Humalog) and 10 units of glargine (Lantus), and remains noncompliant with dietary recommendations despite normal vital signs?
What is the ideal Hemoglobin A1c (HbA1c) level for a patient with uncontrolled Diabetes Mellitus (DM) to be medically cleared for carpal tunnel release surgery?
What is the medical treatment for massive mitral annular calcification with severe left atrial enlargement, presenting with hypertensive emergency and acute pulmonary edema?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.